Randomized controlled trial of vacuum therapy for intermittent claudication. J Vasc Surg 2020; 71: 1692-1701
Published: 15th June 2020
Authors: Hageman D, Fokkenrood HJP, van Deursen BAC, Gommans LNM, Cancrinus E, Scheltinga MRM et al.
In addition to supervised exercise, 78 patients were randomly allocated to vacuum therapy for 30min twice weekly for six weeks, or sham treatment. Improvements in quality of life, treadmill walking distance and ambulatory ability were similar in both groups, with vacuum therapy having no additional benefit.Pubmed Link
You may also be interested in
The effect of supervised exercise, home based exercise and endovascular revascularisation on physical activity in patients with intermittent claudication: a network meta-analysis. Eur J Vasc Endovasc Surg 2019; 58: 383-392
Authors: Van den Houten MML , Hageman D , Gommans LNM, Kleijnen J , Scheltinga MRM , Teijink JAP et al.
Wearable sensor technology efficacy in peripheral vascular disease (wSTEP). A randomized controlled trial. Ann Surg 2018; 268: 1113-1118.
Authors: Normahani P, Kwasnicki R, Bicknell C, Allen L, Jenkins MP, Gibbs R et al.
Systematic review and meta-analysis of clinical trials examining the benefit of exercise programmes using Nordic Walking in patients with peripheral artery disease. Eur J Vasc Endovasc Surg 2018; 56: 534–543.
Authors: Golledge J, Maarij K, Moxon JV, Beard JD, Girold S, Wrang H et al.
A polymer-coated, paclitaxel eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomized non-inferiority trial. Lancet 2018; 392: 1541-1551.
Authors: Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y et al.
Systematic review and meta-analysis of high-pressure intermittent limb compression for the treatment of intermittent claudication. J Vasc Surg 2018; 67: 620–628.e2.
Authors: Oresanya L, Mazzei M, Bashir R, Farooqui A, Athappan G, Roth S et al.
A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication. J Vasc Surg 2018; 67: 514–521.e2.
Authors: Harwood AE, Green J, Cayton T, Raza A, Wallace T, Carradice D et al.
Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease. The HONOR randomized clinical trial. JAMA 2018; 319: 1665-1676.
Authors: McDermott MM, Spring B, Berger S, Treat-Jacobson D, Conte MS, Creager MA et al.
Effect of granulocyte-macrophage colony-stimulating factor with or without supervised exercise on walking performance in patients with peripheral artery disease. The PROPEL randomized clinical trial. JAMA 2017; 318: 2089-2098.
Authors: McDermott MM, Ferrucci L, Tian L, Guralnik JM, Lloyd-Jones D, Kibbe MR et al.
A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg 2015; 61: Suppl 54S–73S.
Authors: Malgor RD, Alalahdab F, Elraiyah TA, Rizvi AZ, Lane M, Prokop LJ et al. et al.
Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization Or Not in Intermittent Claudication (IRONIC) Trial. Circulation 2014; 130: 939-947.
Authors: Nordanstig J, Taft C, Hensäter M, Perlander A, Osterberg K, Jivegård L et al.
The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis. Eur J Vasc Endovasc Surg 2014; 48: 169-184.
Authors: Gommans LNM, Saarloos R, Scheltinga MRM, Houterman S, de Bie RA, Fokkenrood HJP et al. et al.
A randomised controlled trial of supervised exercise regimens and their impact on walking performance, skeletal muscle mass and Calpain activity in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2014; 47: 304-310.
Authors: Delaney CL, Miller MD, Chataway TK, Spark JI